GM
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
16.818
Exchange
XCSE - Nasdaq Copenhagen A/S
15.7 B
Last period Cash and equivalents ,DKK
126%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Genmab
Company Analysis
GMAB.CO valuation, rating, competitors, insights and company profile
Eyestock Rating
GMAB.CO financial analysis by Eyestock methodology
Valuation
GMAB.CO valuation using historical relative method
Statements
GMAB.CO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
GMAB.CO dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Genmab`s Cash and equivalents for the period ended 2024-06-30 are 15.7 B DKK
